SEOUL, Feb. 24 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday its new biosimilar for an autoimmune disease treatment has obtained approval from the European Commission (EC). The EC approved Celltrion’s Avtozma, a biosimilar to Actemra, in both intravenous and subcutaneous formulations, for sales in the member countries of the [...]
SEOUL, Feb. 20 (Korea Bizwire) — South Korean pharmaceutical and biotech companies are scrambling to prepare for potential new tariffs threatened by American President Donald Trump on foreign-made drugs entering the U.S. market. Celltrion, a major South Korean biopharmaceutical company, announced on its website on February 19 that it has established an “optimal response system” to [...]
SEOUL, Feb. 19 (Korea Bizwire) — South Korea’s pharmaceutical and biotech sector has kicked off 2024 with a flurry of merger and acquisition activity, as companies move to strengthen their market positions and diversify their portfolios. GC Wellbeing, a subsidiary of GC Group, recently acquired Inibio, a developer of botox products, in a move to expand [...]
SEOUL, Feb. 6 (Korea Bizwire) – Second Vice Foreign Minister Kang In-sun has discussed ways to deepen cooperation in the critical minerals sector in talks with senior government officials of Tanzania, South Africa and Zimbabwe, Seoul’s foreign ministry said Thursday. The talks took place Wednesday (local time) on the margins of a key mining event [...]
SEOUL, Feb. 6 (Korea Bizwire) — Scientists have discovered that seaweed extracts may help suppress and alleviate inflammation caused by fine dust particles, according to an announcement from Wando County, South Jeolla Province, on February 5. The research, conducted jointly by the Marine Bio Research Center, Jeonbuk National University, and Sunchon National University, focused on identifying [...]
SEOUL, Feb. 6 (Korea Bizwire) — A new study has demonstrated the safety and effectiveness of robot-assisted gait training for patients recovering from spinal surgery, with participants showing an average 39% improvement in their ability to perform daily activities, researchers from Gangnam Severance Hospital announced on February 5. The research team, led by Park Jung-hyun of [...]
SEOUL, Feb. 6 (Korea Bizwire) — Korean scientists have identified a molecular switch that could potentially transform cancer cells back into normal cells by capturing the critical transition moment when healthy cells become cancerous, the Korea Advanced Institute of Science and Technology (KAIST) announced on February 5. The research team, led by Cho Kwang-hyun from the [...]
SEOUL, Jan. 31 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA). The FDA approved Celltrion’s Avtozma, a biosimilar to Actemra, in both intravenous and subcutaneous formulations, according to the company. Avtozma [...]
SEOUL, Jan. 30 (Korea Bizwire) — South Korean drug manufacturers are rapidly expanding their presence in the global autoimmune disease treatment market, challenging the longtime dominance of Western pharmaceutical giants. Autoimmune diseases, which occur when the body’s immune system mistakenly attacks its own organs, tissues, and cells, encompass a range of conditions including rheumatoid arthritis, multiple sclerosis, [...]
SEOUL, Jan. 24 (Korea Bizwire) — The South Korean government has announced an ambitious initiative to position the country as one of the world’s top five biotech powerhouses by establishing a Korean-style bio cluster and accelerating AI- and data-driven biotech research and development (R&D). The plan aims to elevate the biotech industry to a level [...]